Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia

NCT00436683 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Failure

Interventions

DRUG: Fermagate
DRUG: Sevelamer HCl

Sponsor

Ineos Healthcare Limited